Torii, Shiho

SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity

Motozono, C., Toyoda, M., Zahradnik, J., Saito, A., Nasser, H., Tan, T. S., Ngare, I., Kimura, I., Uriu, K., Kosugi, Y., et al. (2021) · Cell Host & Microbe

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 586

SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response

Tsuji, S., Minami, S., Hashimoto, R., Konishi, Y., Suzuki, T., Kondo, T., Sasai, M., Torii, S., Ono, C., Shichinohe, S., et al. (2022) · Nature Aging

Telomeres, Telomerase, and SenescenceCOVID-19 Clinical Research Studies

Cited by 84

The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN

Soh, W. T., Liu, Y., Nakayama, E. E., Ono, C., Torii, S., Nakagami, H., Matsuura, Y., Shioda, T., & Arase, H. (2020) · bioRxiv (Cold Spring Harbor Laboratory)

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 61

Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity

Yoshida, A., Okamura, S., Torii, S., Komatsu, S., Miyazato, P., Sasaki, H., Ueno, S., Suzuki, H., Kamitani, W., Ono, C., et al. (2022) · iScience

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 20

Versatile live attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity

Yoshida, A., Okamura, S., Torii, S., Komatsu, S., Miyazato, P., Ueno, S., Suzuki, H., Kamitani, W., Ono, C., Matsuura, Y., et al. (2021) · iScience

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 20